CellWell record HH-21468
Albuminuria and cardiovascular risk
Rigo DH; Jiménez PM; Orias M
Hipertension y riesgo vascular · 2023
In plain language
In a review, albuminuria as a cardiovascular therapeutic target remained controversial, with SGLT2 blockers reducing cardiovascular events regardless of whether albuminuria is present or how large it is.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-21468
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.